Abstract

Similar to mechanisms of recruitment of activated leukocytes to inflamed tissues, selectins mediate adhesion and extravasation of circulating cancer cells. Our objective was to determine whether sialyl Lewis X modified core 2 O-glycans (C2-O-sLeX) present on colon and hepatic carcinoma cells promote their adhesion and invasion. We examined membrane expression of C2-O-sLeX, selectin binding, invasion of human colon and hepatic carcinoma cell lines, and mRNA levels of alpha-2,3 fucosyltransferase (FucT-III) and core 2 beta-1,6 N-acetylglucosaminyltransferase (C2GnT1) genes, necessary for C2-O-sLeX synthesis, by quantitative reverse-transcriptase (RT) PCR. Synthesis of core 2 branched O-glycans decorated by sLeX is dependent on C2GnT1 function and thus we determined enzyme activity of C2GnT1. The cell lines that expressed C2GnT1 and FucT-III mRNA by quantitative RT-PCR were highly positive for C2-O-sLeX by flow cytometry, and colon carcinoma cells possessed highly active C2GnT1 enzyme. Cells bound avidly to E-selection but not to P- and L-selectin. Gene knock-down of C2GnT1 in colon and hepatic carcinoma cells using short hairpin RNAs (shRNA) resulted in a 40–90% decrease in C2-O-sLeX and a 30–50% decrease in E-selectin binding compared to control cells. Invasion of hepatic and colon carcinoma cells containing C2GnT1 shRNA was significantly reduced compared to control cells in Matrigel assays and C2GnT1 activity was down-regulated in the latter cells. The sLeX epitope was predominantly distributed on core 2 O-glycans on colon and hepatic carcinoma cells. Our findings indicate that C2GnT1 gene expression and the resulting C2-O-sLeX carbohydrates produced mediate the adhesive and invasive behaviors of human carcinomas which may influence their metastatic potential.

Highlights

  • Recognition and binding of selectins to sialyl Lewis X and related oligosaccharides are crucial interactions that regulate leukocyte adhesion to blood vessels and extravasation into tissues in an inflammatory response [1]

  • We examined the participation of C2-O- sialyl Lewis X (sLeX) in E-selectin binding of LS174T and HepG2 cells by detecting the ability of these carcinoma cell lines expressing C2-O-sLeX to bind to a mouse E-selectin Fc chimera by flow cytometry

  • LS174T and HepG2 cells with high endogenous C2-O-sLeX expression bound avidly to E-selection (98% and 95% cellular mRNA transcripts in LS174T colorectal adenocarcinoma and HepG2 hepatic carcinoma cell lines were detected by RT-PCR. (B) Flow cytometric analysis of positive staining of LS174T and HepG2 cells labeled with CHO-131 monoclonal antibody (mAb)

Read more

Summary

Introduction

Recognition and binding of selectins to sialyl Lewis X (sLeX) and related oligosaccharides are crucial interactions that regulate leukocyte adhesion to blood vessels and extravasation into tissues in an inflammatory response [1]. C2O-sLeX decorates the mucin P-selectin glycoprotein ligand-1 (PSGL1, CD162) and is important for high-strength binding interactions with P-selectin [11,12,13,14]. Gastric, lung, pancreatic, prostate, and urinary bladder highly express the selectin ligand sLeX and expression is significantly correlated with advanced disease and a poor prognosis [16,17,18,19,20,21].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call